ArticleHypertension research : official journal of the Japanese Society of Hypertension2024

Another evidence that supports the continued use of RAS inhibitors in end-stage kidney diseases.

Osamu Yamazaki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.